Showing results (51-60 of 85) with videos related to
Sort By:
Pageof 9
Leukemia|January 30, 2004
Effect of thalidomide therapy on bone marrow angiogenesis in multiple myelomaS Kumar, T E Witzig, A Dispenzieri, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
Prognostic value of bone marrow angiogenesis in multiple myelomaS V Rajkumar, T Leong, P C Roche, et al.Bone Marrow Transplantation|June 1, 2004
Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapyS Kumar, M A Gertz, A Dispenzieri, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2001
Eligibility for hematopoietic stem-cell transplantation for primary systemic amyloidosis is a favorable prognostic factor for survivalA Dispenzieri, M Q Lacy, R A Kyle, et al.Leukemia|April 12, 2003
Thalidomide as initial therapy for early-stage myelomaS V Rajkumar, M A Gertz, M Q Lacy, et al.Bone Marrow Transplantation|December 2, 2000
Effect of complete response on outcome following autologous stem cell transplantation for myelomaS V Rajkumar, R Fonseca, A Dispenzieri, et al.Bone Marrow Transplantation|May 11, 2004
High-dose therapy and autologous stem cell transplantation for multiple myeloma poorly responsive to initial therapyS Kumar, M Q Lacy, A Dispenzieri, et al.Bone Marrow Transplantation|August 3, 2004
Single agent dexamethasone for pre-stem cell transplant induction therapy for multiple myelomaS Kumar, M Q Lacy, A Dispenzieri, et al.Bone Marrow Transplantation|March 20, 1999
Early harvest and late transplantation as an effective therapeutic strategy in multiple myelomaM A Gertz, M Q Lacy, D J Inwards, et al.Leukemia|May 13, 2015
Utility of serum free light chain measurements in multiple myeloma patients not achieving complete response to therapyM Alhaj Moustafa, S V Rajkumar, A Dispenzieri, et al.Pageof 9